USPTO serial 79259556
WACKER
Reviewed by CopyMark Law Group
Reg. 6092969Status 708Renewal
- Filing date
- Status date
- Registration date
- Jul 7, 2020
- Examiner
- PETTICAN, NATHANIEL VINCIENT
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with WACKER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,493*
Plus Government fees of $2,975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel M. Gurfinkel
Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated cosmetics and toiletry preparations; non-medicated dentifrices; perfumery; essential oils; bleaching preparations and other substances for laundry use, namely, fabric softeners, detergent, wax, glaze; cleaning, polishing, scouring and abrasive preparations; artificial and natural fragrances and aromatic oils, and solutions, mixtures and preparations thereof, namely, creams, lotions, body sprays, emulsions, dispersions, soaps, oil and powders; perfume oils for the manufacture of cosmetic preparations; non-medicated dental care preparations, namely, chewing gum, chewing candy, toothpaste, tooth gel, dental floss and mouth wash; chewable dentifrices; dentifrices in the form of chewing gum; cosmetic dyes, namely, hair dyes and beard dyes; cosmetic preparations for slimming purposes; cosmetics based on disaccharides, oligosaccharides, polysaccharides or derivates or complexes thereof; cosmetics based on cyclodextrins, cyclodextrin derivates or complexes thereof; cosmetics based on phenols or phenol derivatives; cosmetics based on antioxidants; cosmetics based on silicones, silanes and silica | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment and prevention of infectious diseases, injuries, muscle diseases, obstructive airway diseases, cirrhosis, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth, and for maintenance of redox homeostasis in cells or for hair and skin care; medical and veterinary preparations for treating gastrointestinal illnesses and pain relief medication and for the treatment of intestinal bacteria; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, namely, food and substances comprising or made of cyclodextrins, cyclodextrin derivatives, phenols, phenol derivatives, hydroxytyrosol, ubiquinone, ubiquinol, amino acids, antioxidants; food for babies; dietary supplements for humans and animals; medical plasters; materials for dressings, namely, bandages, gauze wadding; material for stopping teeth; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic preparations in the form of additives and auxiliaries adapted for medical and veterinary purposes, namely, cyclodextrins, cyclodextrin derivatives, phenols, phenol derivatives, hydroxytyrosol, ubiquinone, ubiquinol, amino acids, antioxidants; dietetic beverages adapted for medical use; enzymes or enzyme preparations for medical or veterinary purposes; medicated cosmetics; oils for medical purposes; medicated animal feed; vitamin fortified beverages for medical purposes; nutraceuticals for use as a dietary supplement for therapeutic or medical purposes, namely, the treatment and prevention of infectious diseases, injuries, muscle diseases, obstructive airway diseases, cirrhosis, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth, and for maintenance of redox homeostasis in cells or for hair and skin care; vitamin preparations; antioxidants for medical or veterinary purposes or in the form of dietary supplements; medicines and dietary supplements based on disaccharides, oligosaccharides, polysaccharides or derivates or complexes thereof for the treatment and prevention of infectious diseases, injuries, muscle diseases, obstructive airway diseases, cirrhosis, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth, and for maintenance of redox homeostasis in cells or for hair and skin care; medicines and dietary supplements based on cyclodextrins, cyclodextrin derivates or complexes thereof for the treatment and prevention of infectious diseases, injuries, muscle diseases, obstructive airway diseases, cirrhosis, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth, and for maintenance of redox homeostasis in cells or for hair and skin care; medicines and dietary supplements based on phenols or phenol derivatives for the treatment and prevention of infectious diseases, injuries, muscle diseases, obstructive airway diseases, cirrhosis, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth, and for maintenance of redox homeostasis in cells or for hair and skin care; organic acids and derivatives thereof for dietetic, medical or veterinary purposes or in the form of dietary supplements; amino acids or amino acid derivatives for dietetic, medical or veterinary purposes or in the form of dietary supplements; biological preparations for medical or veterinary purposes or in the form of dietary supplements for the treatment of the treatment and prevention of infectious diseases, injuries, muscle diseases, obstructive airway diseases, cirrhosis, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth, and for maintenance of redox homeostasis in cells or for hair and skin care; medicated dentifrices; chewing gum for medical purposes; medicines and dietary supplements based on silicones, silanes and silica for intestinal disorders, for the treatment of gastrointestinal diseases; biocides; dental, otoplastic and ophthalmological preparations and material for dental prostheses made of organosilicon compounds and their composition | ACTIVE | — |
| 007 | [ Machines for plastics processing and milling, grinding, mixing, extruding, coating and laminating machines for the treatment of materials, namely, for plastics and metal; 3D printers ] | SECTION 71 - CANCELLED | — |
| 009 | Apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity, namely, batteries; lithium-ion batteries; anodes; apparatus, instruments and cables for electricity, namely, lithium-ion battery cells for electrical appliance construction and power supply in the fields of plant construction, automation, batteries, consumer electronics, electric vehicles, electrical power engineering, cables, high voltage capacitors, transformers, and defense technology; electrical and electronic components, namely, lithium-ion battery cells for electrical appliance construction and power supply in the fields of plant construction, automation, batteries, consumer electronics, electric vehicles, electrical power engineering, cables, high voltage capacitors, transformers, and defense technology; blank magnetic data carriers; blank recordable optical discs; blank compact discs; blank DVD-Rs and digital recording media, namely, CD-Rs, CD-ROMS; downloadable data processing programs recorded on data carriers; photovoltaic systems that convert sunlight into electric and thermal energy; photovoltaic apparatus and installations for generating solar power, namely, solar modules, thermal hybrid modules, roofing members, cladding panels; solar wafers; solar cells; photovoltaic solar modules; components for installing photovoltaic modules being parts specially adapted for the aforesaid photovoltaic installations and apparatus; solar batteries; solar collectors for electricity generation; silicon wafers; semi-conductor wafers; biosensors for the detection of chemical substances; contact lenses | ACTIVE | — |
| 019 | Asphalt; non-metallic building materials, namely, artificial stone, wood-plastic composites, concrete based compounds, spackling compounds, tar-based compounds and asphalt patching compounds made from polymer dispersions and powders for use in the building industry; non-metal shelter structures; concrete, shotcrete; concrete components, namely, blocks, bricks, posts, slabs, panels; fire-retardant building materials, not of metal; floors, not of metal; ducts, not of metal; grout; asphalt, concrete, shotcrete, cement, tar, bitumen coatings for coatings, roofs, fireproofing, building foundations, roads, tunnels; binding material for road repair, namely, asphalt, concrete, shotcrete, cement, tar, bitumen; materials for making and coating roads, namely, asphalt, concrete, shotcrete, cement, tar, bitumen; tar; water-pipes, not of metal; geotextile lining for use in tunnel construction | ACTIVE | — |
| 040 | Customized manufacture of models and prototypes and custom small-series production of models and prototypes; customized production of substances based on amino acids, namely, amino acids, peptides, proteins and antibodies; customized production of proteins; plastics processing; plastics treatment; processing of foodstuffs for use in manufacture; treatment of foodstuffs; production of 3D prints; rental of 3D printers | ACTIVE | — |
| 041 | Educational services, namely, providing classes, seminars, workshops in the fields of chemistry, physics, biotechnology, engineering and marketing; providing of training in the form of classes, seminars, workshops in the field of chemistry, physics, biotechnology, engineering and marketing; organizing community sporting and cultural activities; providing educational information in the academic field of science for the purpose of academic study; publication of books, magazines, brochures, calendars and providing of non-downloadable electronic publications in the nature of books and magazines in the field of chemistry, physics, biotechnology, engineering and marketing; writing of articles for professional journals other than for advertising or publicity; arranging training courses; providing of advanced training in the field of chemistry, physics, biotechnology, engineering and marketing; providing of further training in the field of chemistry, physics, biotechnology, engineering and marketing; educational support, namely, providing tutoring in the field of chemistry, physics, biotechnology, engineering and marketing; organization and arranging of educational conferences; organization and arranging of educational congresses | ACTIVE | — |
| 042 | Scientific and technological services, namely, design, research, development, production and testing services in the field of chemistry, physics, biotechnology and engineering; industrial analysis and research services in the field of chemistry, physics, biotechnology and engineering; design and development of computer hardware and software; scientific research, development and consultancy related thereof in the chemistry sector; scientific research, development and consultancy related thereof in the biotechnology sector; scientific research, development and consultancy related thereof in the technology sector; scientific research, development and consultancy related thereof in the foodstuff technology sector; research and development of new products, for others; preparation of technical documentation in the field of chemistry, physics, biotechnology and engineering; chemistry services, namely, design, research, development, production and testing services; biology services, namely, design, research, development, production and testing services; biotechnology services, namely, design, research, development, production, and testing services physics research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Wacker Chemie AG
- Other trademarks owned by Wacker Chemie AG
- Other trademarks owned by Wacker Chemie AG
- Other trademarks owned by Wacker Chemie AG
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 019
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named WACKER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 22, 2026 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 7, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 24, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jul 7, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 6, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 28, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 29, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 29, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 7, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 10, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 10, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 4, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 11, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 21, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 21, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 21, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 21, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 30, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 30, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 9, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jul 11, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 10, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 30, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |